Chemical Structure : CDK9 PROTAC C3
Catalog No.: PC-24046Not For Human Use, Lab Use Only.
CDK9 PROTAC C3 is a potent and selective, oral CDK9 PROTAC degrader with DC50 of 1.09 nM in NCI-H69 cells.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CDK9 PROTAC C3 is a potent and selective, oral CDK9 PROTAC degrader with DC50 of 1.09 nM in NCI-H69 cells.
CDK9 PROTAC C3 induces selective CRBN-mediated degradation of CDK9, decreases phosphorylation of RNA Pol II at Ser2 and Ser5, as well as reduced expression of c-Myc in NCI-H446 cells.
CDK9 PROTAC C3 exhibits excellent cytotoxicity against SCLC cell lines (NCl-H69, NCl-H146, NCl-H446, NCl-H524, and DMS114) (IC50 = 0.530 to 3.768 nM), significantly blocks the formation of malignant clone.
CDK9 PROTAC C3 strongly triggers apoptosis in NCI-H69 and NCI-H446 cells in a dose-dependent manner, attenuates the invasion of SCLCs.
CDK9 PROTAC C3 (12.5 and 25 mg/kg, QD) demonstrates significant tumor suppression (TGI = 79.2% and 84.8%, respectively) in NCI-H446 subcutaneous xenograft model.
M.Wt | 807.78 | |
Formula | C39H48Cl2N10O5 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Wang Y, et al. J Med Chem. 2025 Feb 2. doi: 10.1021/acs.jmedchem.4c01621.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright